Generic Names of Some Trade Name Drugs, THE MERCK MANUAL OF HEALTH & AGING
Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs -~ Generic Names of Some Trade Name Drugs - Generic Names of Some...
Some Trade Names of Generic Drugs, THE MERCK MANUAL OF HEALTH & AGING
Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs-~ Generic Names of Some Trade Name Drugs - Some Trade Names of...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, CALAN to CYTOXAN
Trade Names of Some Commonly Used Drugs TRADE AND GENERIC NAMES OF COMMONLY USED DRUGS CALAN to CYTOXAN Trade Name Generic CALAN Verapamil CALCIMAR Calcitoninsalmon CALDEROL Calcifediol CAPASTAT Capreomycin CAPOTEN Captopril CARAFATE Sucralfate CARDENE Nicardipine CARDIOQUIN Quinidine CARDIZEM Diltiazem CARDURA Doxazosin CARTROL Carteolol CATAFLAM Diclofenac CATAPRES Clonidine...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, Kanamycin to Moxalactam
Trade Names of Some Commonly Used Drugs GENERIC AND TRADE NAMES OF COMMONLY USED DRUGS Kanamycin to Moxalactam Generic Trade Name Kanamycin KANTREX Ketoconazole NIZORAL Ketoprofen ORUDIS, ORUVAIL Ketorolac TORADOL Labetalol NORMODYNE, TRANDATE Lactulose CEPHULAC, CHRONULAC Lamivudine EPIVIR Lamotrigine LAMICTAL Lansoprazole PREVACID Latanoprost XALATAN Leflunomide ARAVA Levallorphan...
Introduction: Allergic Reactions: Merck Manual Home Edition
If the person has mild reactions to immunotherapy (such as sneezing, coughing, flushing, tingling sensations, itching, chest tightness, wheezing, and hives), a drug—usually an antihistamine, such as diphenhydramine Some Trade Names BENADRYL NYTOL SOMINEX or loratadine Some Trade Names CLARITIN —may help. Some Antihistamines Drug Degree of Anticholinergic Effects ...
Oral antihistamines for atopic dermatitis - [Medication] - Quest Diagnostics Patient Health Library
Oral antihistamines for atopic dermatitis Examples Brand Name Chemical Name Benadryl diphenhydramine hydrochloride Atarax, Marax, Marax-DF hydroxyzine Optimine, Trinalin Repetabs azatadine maleate Zyrtec cetirizine hydrochloride [less sedating] Claritin loratadine [nonsedating] Allegra fexofenadine [nonsedating] How It Works Antihistamines reduce itching by blocking chemical ...
Antihistamines for allergic rhinitis - [Medication] - Quest Diagnostics Patient Health Library
Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About Antihistamines for allergic rhinitis - [Medication] - Quest Diagnostics Patient Health Library Antihistamines for allergic rhinitis - [Medication] - Quest Diagnostics Patient Health Library acrivastine, Alavert, Allegra, Allergic, allergic disorder, Allergies, Allergy,...
e_s01_s52_FF12
FACTS & FIGURES 2005 CARING AND CURING ©Novartis AG, July 2005. Decades of experience and know- how make Sandoz a renowned partner in pharmaceuticals, biogenerics, and anti- infectives. novartis. Chairman and CEO Urs Baerlocher, J. Singh Finance & Administration Thomas van Laar Technical Operations BUSINESS UNIT HEADS David Epstein Specialty Medicines and Oncology...
duplicates:http://www.novartis.com/downloads/Nov_F_F05_E.pdf
Nov.F&F04_E_12.qxd
FACTS & FIGURES 2004/ 2005 CARING AND CURING 1 OUR MISSION We want to discover, develop and successfully market innovative products to cure diseases, to ease suffering and to enhance the quality of life. CONSUMER HEALTH The Consumer Health Division focuses on creating, developing and manufacturing a wide range of competitively differentiated products that restore, maintain or...
author: comfactory
duplicates:http://www.novartis.com/downloads/Nov_F_F04_E.pdf
BioPortfolio Limited
TABLE OF CONTENTS CHAPTER 1 EXECUTIVE SUMMARY 3 Objective of the analysis 3 Scope and focus 3 Datamonitor insight into the allergic rhinitis market 4 CHAPTER 2 PATIENT POTENTIAL 13 Patient potential 13 Epidemiology 14 Age variance 15 Global prevalence 16 Methodology 16 US 16 EU 17 Japan 22 Loratadine: the gold standard in allergic rhinitis 23 Associated pharmaceutical markets...
Teva Pharmaceutical Industries - News and PR
- - Search Tevapharm: - - Press Release Teva Confirms Exercise of Option Under Collaboration with Impax Laboratories, Inc. Food and Drug Administration (FDA), included: Loratadine/Pseudoephedrine Sulfate 12 hour Extended Release Tablets (generic of Claritin ® D12), Loratadine/Pseudoephedrine Sulfate 24 hour Extended Release Tablets (generic of Claritin ® D24), ...
Teva Pharmaceutical Industries - News and PR
- - Search Tevapharm: - - Press Release Teva Received Two Approvals:Final Approval for Enalapril to be Shipped Immediately Tentative Approval for Loratadine Jerusalem, Israel, August 23, 2000 - Teva Pharmaceutical Industries Ltd. Enalapril Maleate is the generic version of Mercks Vasotec® which is an ACE inhibitor indicated for the treatment of hypertension.
Novartis Press Kit English page 40
author: guestnc1
duplicates:http://www.novartis.com/downloads/press_kit.pdf
Specificity Table TOX.xls
Tested (ng/ ml) Chlor- Trimeton Chlorpheniramine Antihistamine 100,000 Chocolax Phenolphthalein Laxative 100,000 Cholesterol Cholesterol Emulsifying agent 100,000 Cibazol Sulfathiazole Antibacterial 100,000 Cinchovatine Cinchonidine Antimalarial 100,000 Cinobal Cinoxacin Antibacterial 100,000 Cipro Ciprofloxacin Antibacterial 100,000 Citanest Prilocaine Anesthetic 200,000 Claforan...
author: Biosite Incorporated
Specificity Table TOX.xls page 6
author: Biosite Incorporated
Pediatric Exclusivity Labeling Changes
Food and Drug Administration Center for Drug Evaluation and Research Pediatrics Search Pediatric Exclusivity Labeling Changes as of February 6, 2004 - - Exclusivity Granted (Labeled) Product Indications Label Changes 1 8/14/00 (12/4/00) Loratadine - Claritin (Schering) Label [PDF ] Allergic rhinitis/Urticaria Labeling for 2 - 5 year olds including information on...
Paragraph IV Patent Certifications
- DRUG NAME DOSAGE FORM STRENGTH RLD Acetaminophen Extended-release Tablets 650 mg Tylenol Acetaminophen/ Aspirin/ Caffeine Tablets 250 mg/250 mg/ 65 mg Excedrin (migraine) Acetaminophen and Tramadol Hydrochloride Tablets 325 mg/ 37.5 mg Ultracet Acyclovir Sodium1 Injection 50 mg/mL, 10 mL and 20 mL vials Zovirax Albuterol Sulfate Oral Syrup 2 mg(base)/ 5 mL Ventolin Albuterol...
http://www.fda.gov/cder/orange/appendix_a.txt
3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE #3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE, ACETAMINOPHEN ACETAMINOPHEN, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN, BUTALBITAL AND CAFFEINE, ACETAMINOPHEN ACETAMINOPHEN,...
EFFICACY SUPPLEMENTS APPROVED IN CALENDAR YEAR 2003
FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - - EFFICACY SUPPLEMENTS APPROVED IN CALENDAR YEAR 2003 (SE1 -SE7)* and EFFICACY SUPPLEMENTS APPROVED IN CALENDAR YEAR 2003 (SE8)* - GENERIC NAME APPLICANT NDA NUMBER SUPP TYPE SUPP NUMBER RECEIPT DATE APPROVAL DATE PRIORITY REVIEW TOTAL APPROVAL TIME (MONTHS) INDICATION/DESCRIPTION FLUOXETINE...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, CALAN to CYTOXAN
Trade Names of Some Commonly Used Drugs TRADE AND GENERIC NAMES OF COMMONLY USED DRUGS CALAN to CYTOXAN Trade Name Generic CALAN Verapamil CALCIMAR Calcitoninsalmon CALDEROL Calcifediol CAPASTAT Capreomycin CAPOTEN Captopril CARAFATE Sucralfate CARDENE Nicardipine CARDIOQUIN Quinidine CARDIZEM Diltiazem CARDURA Doxazosin CARTROL Carteolol CATAFLAM Diclofenac CATAPRES Clonidine...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, Kanamycin to Moxalactam
Trade Names of Some Commonly Used Drugs GENERIC AND TRADE NAMES OF COMMONLY USED DRUGS Kanamycin to Moxalactam Generic Trade Name Kanamycin KANTREX Ketoconazole NIZORAL Ketoprofen ORUDIS, ORUVAIL Ketorolac TORADOL Labetalol NORMODYNE, TRANDATE Lactulose CEPHULAC, CHRONULAC Lamivudine EPIVIR Lamotrigine LAMICTAL Lansoprazole PREVACID Latanoprost XALATAN Leflunomide ARAVA Levallorphan...
1997 Warning Letters and Notice of Violation Letters to Pharmaceutical Companies
DDMAC 7/2/1997 7/21/1997 Rowasa (mesalamine) rectal suspension enema Solvay Pharmaceuticals DDMAC 7/14/1997 7/21/1997 Vancenase, Vancenase AQ, Vanceril Schering Corporation DDMAC 7/31/1997 9/22/1997 Viramune (Nevirapone) Boehringer Ingelheim DDMAC 7/2/1997 6/3/1998 August 1997 Acular (Ketorlac Tromethamine) Hoffman-LaRoche DDMAC 8/18/1997 6/2/1998 Biaxin (Clarithromycin) Abbott...
Microsoft PowerPoint - FRESCO 2003 Christian Seiwald 2004-01-21 Analysts print.ppt
1 Sandoz A Leader in the Generics Marketplace Christian Seiwald CEO Sandoz 2 FRESCO 2003 / Christian Seiwald / 2004-01-22 / Analysts Agenda ° Sandoz performance 2003 ° Generics market dynamics ° Sandoz strategy 2 3 FRESCO 2003 / Christian Seiwald / 2004-01-22 / Analysts Record Performance of Sandoz in 2003 ° Outstanding business results: Sales +60% in USD, ...
author: releano1
duplicates:http://www.novartis.com/downloads_new/investors/Seiwald_Analyst_Web.pdf
Microsoft PowerPoint - FRESCO 2003 Paul Choffat 2004-01-21 Media Print.ppt
Nutrition & Sante 2 US Baby Food only Source: Internal market research, IMS, Nicholas Hall, Wood MacKenzie, IRI 9% 3% 7% 1% 3% 4% 9% 3% 5% 7% 0% Sandoz OTC AH MN I&B; CV 1 47% 2 3 5 FRESCO 2003 / Paul Choffat / 2004-01-22 / Media Sandoz Builds on Top-Tier Position in Generics Industry ° Outstanding business results Sales +60% in USD, +47% in LC Operating income +78...
author: releano1
Microsoft PowerPoint - FRESCO 2003 Paul Choffat 2004-01-21 Media Print.ppt page 4
author: releano1